Qiagen NV | QIA - Cost Of Sales

Stock Price
43.17
Daily Change
-0.31 -0.70%
Monthly
1.90%
Yearly
8.86%
Q1 Forecast
43.53

Qiagen NV reported $187.78M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
argenx SE USD 109.43M 1.32M Sep/2025
Avita Medical AUD 3.47M 1.19M Jun/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 207M 88M Sep/2025
Organon & Co USD 745M 25M Sep/2025
Qiagen NV USD 187.78M 11.47M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Viatris USD 2.39B 139.2M Sep/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025